Home » IntegenX Launches Next-Generation Rapid Forensic DNA Platform

IntegenX Launches Next-Generation Rapid Forensic DNA Platform

Sep 03, 2015
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) — IntegenX, a manufacturer of short tandem repeat PCR-based rapid DNA profiling platforms, has launched a next-generation instrument.

Called RapidHit ID, the platform processes a single buccal swab in about 70 minutes with little hands on time and no laboratory expertise required.

The new instrument is ultimately designed to enable decentralized DNA testing of suspects in places like booking stations and police precincts, and the cost of running samples on it will be about one quarter that of the firm's first-generation platform, the RapidHit System.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Passing on Trauma, Maybe

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

Told to Pause

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

This Week in PNAS

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In PCR

  1. PredictImmune Gains CE-IVD Mark for IBD Test

  2. Novacyt to Sell Cytology, Clinical Lab Units

  3. Novartis Drug Shows Promise in PIK3CA Mutated Breast Cancer, Potential Utility of ctDNA Testing

    Premium

  4. Qiagen to Develop Companion Dx for Novartis Breast Cancer Drug

  5. Cancer Early Detection Firm Ark Launches With $40M Series A Investment

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.